Fed. Circ. Shoots Down Appeal In Eye Drug Patent Fight
The Federal Circuit has thrown out an appeal Allgenesis Biotherapeutics filed challenging a Patent Trial and Appeal Board decision that said it did not show that claims of a Cloudbreak Therapeutics...To view the full article, register now.
Already a subscriber? Click here to view full article